approval
saveCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
community read0 votes
Sponsor: INTRA-CELLULAR. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 6
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalNov 5, 2025 · 380d ago
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalJun 28, 2023 · 1241d ago
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalDec 17, 2021 · 1799d ago
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalDec 17, 2021 · 1799d ago
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalDec 20, 2019 · 2527d ago
- approvalCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvalDec 20, 2019 · 2527d ago
comments(0)
5-min edit window · permanent after that